Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
The joint initiative is called J-ARC Healthcare Solutions
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
Zydus unveils its ‘innovation and care’ centric corporate brand identity
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences
Subscribe To Our Newsletter & Stay Updated